Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae isolates recovered in Italy from 1993 to 1996

A Marchese1, M Ramirez, G C Schito

  • 1The Rockefeller University, New York, USA.

Insights

Penicillin-resistant Streptococcus pneumoniae strains in Italy showed international epidemic clones and a novel Italian clone. These resistant strains carried multiple drug resistance traits and specific serotypes, highlighting evolving antibiotic resistance patterns.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Epidemiology

Background:

  • Penicillin resistance in Streptococcus pneumoniae is a growing public health concern.
  • Understanding the molecular epidemiology of resistant strains is crucial for effective treatment and control.

Purpose of the Study:

  • To characterize penicillin-resistant Streptococcus pneumoniae isolates from Italy.
  • To identify the genetic relatedness, serotypes, and antibiotic resistance profiles of these isolates.
  • To investigate the presence of international epidemic clones and novel clones.

Main Methods:

  • Analysis of 39 penicillin-resistant Streptococcus pneumoniae isolates from Italy (1993-1996).
  • Serotyping, antibiotic susceptibility testing, pulsed-field gel electrophoresis (PFGE) for chromosomal relatedness.
  • Restriction fragment length polymorphism (RFLP) of penicillin-binding protein (PBP) genes.
  • DNA hybridization for antibiotic resistance genes.

Main Results:

  • Thirty isolates exhibited high penicillin MICs (≥1 µg/ml) and co-resistance to multiple drugs.
  • Two international epidemic clones (Spanish/USA and French/Spanish) were identified, including a potential capsular transformation event.
  • A novel 'Italian' clone with unique molecular characteristics and multi-drug resistance was discovered.

Conclusions:

  • Penicillin-resistant Streptococcus pneumoniae in Italy are associated with international epidemic clones and emerging novel clones.
  • Molecular characterization reveals complex genetic backgrounds and resistance mechanisms.
  • Findings underscore the dynamic nature of antibiotic resistance and the need for ongoing surveillance.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...